MOH — authorised 30 August 2007
- Marketing authorisation holder: IPSEN PHARMA
- Status: likely_approved
🇮🇱 Somatuline Depot in Israel
MOH authorised Somatuline Depot on 30 August 2007
Marketing authorisation
Somatuline Depot in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in Israel
Frequently asked questions
Is Somatuline Depot approved in Israel?
Yes. MOH authorised it on 30 August 2007.
Who is the marketing authorisation holder for Somatuline Depot in Israel?
IPSEN PHARMA holds the Israeli marketing authorisation.